Evidence map›Paper›PMID 38889372›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.

José Luis Sandoval, Maria Alice Franzoi, Antonio di Meglio, Arlindo R Ferreira, Alessandro Viansone, Fabrice André, Anne-Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier and 10 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01993498 (A Prospective Cohort to Investigate Survivorship Issues in Patients With Early Cancer), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01993498 narecruitingnot on this map

A Prospective Cohort to Investigate Survivorship Issues in Patients With Early Cancer

TypeinterventionalSponsorUNICANCERRan2012 to 2034Enrolled14,750ConditionsBreast Cancer Nos Metastatic Recurrent, Early Lung CancerArmsblood sampling
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

José Luis SandovalUnit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-6256-7083
Maria Alice FranzoiUnit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.ORCID 0000-0002-2470-6054
Antonio di MeglioUnit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.ORCID 0000-0002-0233-3189
Arlindo R FerreiraUniversidade Católica Portuguesa, Lisbon, Portugal.ORCID 0000-0002-1567-9322
Alessandro ViansoneMedical Oncology Department, Gustave Roussy Institute, Villejuif, France.
Fabrice AndréUnit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.ORCID 0000-0001-5795-8357
Anne-Laure MartinUNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.ORCID 0000-0002-9302-8576
Sibille EverhardUNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.ORCID 0000-0002-3151-5707
Christelle JouannaudInstitut Godinot, Reims, France.
Marion FournierInstitut Bergonié, Bordeaux, France.
Philippe RouanetInstitut régional du Cancer de Montpellier-Val d'Aurelle, Montpellier, France.ORCID 0000-0003-0415-3269
Laurence VanlemmensCentre Oscar Lambret, Lille, France.
Asma Dhaini-MerimecheInstitut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre lès Nancy, France.ORCID 0000-0002-2124-7382
Baptiste SautereyInstitut de Cancérologie de L'ouest-Site Angers, Angers, France.ORCID 0000-0001-9160-7307
Paul CottuInstitut Curie, Paris, France.ORCID 0000-0001-6434-3932
Christelle LevyCentre François Baclesse, Caen, France.
Silvia StringhiniUnit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Idris GuessousUnit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Ines Vaz-LuisUnit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.ORCID 0000-0002-7194-2260
Gwenn MenvielleUnit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.ORCID 0000-0002-3261-6366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSocioeconomic status (SES) influences the survival outcomes of patients with early breast cancer (EBC). However, limited research investigates social inequalities in their quality of life (QoL). This study examines the socioeconomic inequalities in QoL after an EBC diagnosis and their time trends. PATIENTS AND

methodsWe used data from the French prospective multicentric CANTO cohort (ClinicalTrials.gov identifier: NCT01993498), including women with EBC enrolled between 2012 and 2018. QoL was assessed using the European Organisation for Research and Treatment of Cancer QoL Core 30 questionnaire (QLQ-C30). summary score at diagnosis and 1 and 2 years postdiagnosis. We considered three indicators of SES separately: self-reported financial difficulties, household income, and educational level. We first analyzed the trajectories of the QLQ-C30 summary score by SES group. Then, social inequalities in QLQ-C30 summary score and their time trends were quantified using the regression-based slope index of inequality (SII), representing the absolute change in the outcome along socioeconomic gradient extremes. The analyses were adjusted for age at diagnosis, Charlson Comorbidity Index, disease stage, and type of local and systemic treatment.

resultsAmong the 5,915 included patients with data on QoL at diagnosis and at the 2-year follow-up, social inequalities in QLQ-C30 summary score at baseline were statistically significant for all SES indicators (SII

conclusionThe magnitude of preexisting inequalities in QoL increased over time after EBC diagnosis, emphasizing the importance of considering social determinants of health during comprehensive cancer care planning.

Indexed as

Breast NeoplasmsQuality of LifeSocioeconomic FactorsAdultAgedFemaleFranceHumansMiddle AgedProspective StudiesSocial ClassSurveys and Questionnaires

Identifiers

PMID38889372
PMCPMC11328924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.